| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/15/2004 | WO2004009827A3 Preparation of microbial oil containing polyunsaturated fatty acids |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003089457B1 Peptide inhibitors of protein kinase c ϝ for pain management |
| 04/15/2004 | WO2003082893A3 Theraputic methods and uses of sapogenins and their derivatives |
| 04/15/2004 | WO2003061555A3 West nile vaccine |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |
| 04/15/2004 | WO2003053359A3 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 04/15/2004 | WO2003039449A3 Modulation of dopaminergic neurons |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003013433A3 Sequestered antagonist formulations |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073280 Method of controlling body temperature while reducing shivering |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072869 Bipolar disorders; psychological diseases |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072861 Anxiolytic agents |
| 04/15/2004 | US20040072855 Crystallization, mixing with solvent at low temperature; therapy for central nervous system disorders |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 04/15/2004 | US20040072845 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl] piperazine |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072821 N-substituted glycine derivatives |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072806 Neuroprotective spirostenol pharmaceutical compositions |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072344 Differentiating pluripotent stem cells into pancreatic or nervous system tissues for treatment of nervous system and pancreatic disorders; transplant therapy; tissue engineering |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072177 Novel human serine-threonine kinase |
| 04/15/2004 | US20040072174 Calpain protease 12 |
| 04/15/2004 | US20040071802 Contacting cell with an amount of a Cimicifuga extract or of an active fraction thereof effective for reducing level of A beta polypeptide in or secreted from said cell and monitoring level of A beta polypeptide in or secreted from cell |
| 04/15/2004 | US20040071686 Treatment of alpha-galactosidase A deficiency |
| 04/15/2004 | US20040071675 Retrograde transport delivering entity of interest to tyrosine hydroxylase positive neuron; Parkinson's disease; rabies g protein transduction |
| 04/15/2004 | US20040069523 Use of Vitamin D-Derivatives in the Treatment of Osteoporosis and related bone disorders, as well as novel vitamin D3-Deviratives |
| 04/15/2004 | DE19906975B4 Arzneiform zur Behandlung von Alzheimer'scher Demenz Dosage form for the treatment of Alzheimer's dementia |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/15/2004 | DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia |
| 04/15/2004 | DE10246357A1 Medicaments for prolonging both REM and non-REM sleep, containing 5-HT-2 receptor antagonists, preferably N-(indolyl-carbonyl)-piperazine derivatives |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2501237A1 Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz [b,f]azepine-5-carboxamide and new crystal forms thereof |
| 04/15/2004 | CA2501017A1 Remedies |
| 04/15/2004 | CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | CA2500966A1 Novel sulphones for inhibition of gamma secretase |
| 04/15/2004 | CA2500904A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | CA2500672A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/15/2004 | CA2500664A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/15/2004 | CA2500088A1 Morpholine-bridged indazole derivatives |
| 04/15/2004 | CA2499736A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | CA2498337A1 Hydroxyphenylundecane derivatives, a process for their production and their use |
| 04/15/2004 | CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/14/2004 | EP1408333A2 Diagnosis and treatment of Alzheimer's disease |
| 04/14/2004 | EP1408042A1 Novel isoxazolopyridone derivatives and use thereof |
| 04/14/2004 | EP1408039A2 Mixed paraxetine propan-2-ol solvates |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1407782A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 04/14/2004 | EP1407770A1 Tgf-beta superfamily production/secretion promoter |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407269A2 A method for diagnosing a person having multiple sclerosis |
| 04/14/2004 | EP1407043A2 Gamma-secretase in vitro screening assay |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407010A1 Regulation of human aminopeptidase n |
| 04/14/2004 | EP1407004A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 04/14/2004 | EP1406926A2 Novel neurotrophic factors |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 04/14/2004 | EP1406902A1 Hexahydroazepino(4,5-g)indoles and indolines as 5-ht receptor ligands |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406897A2 Compounds |
| 04/14/2004 | EP1406895A1 Lactone formulations and method of use |